Federal vaccine advisory committee, led by Health Secretary Robert F. Kennedy Jr, has made a significant decision without any concrete evidence to back it up. The panel unanimously voted to scrap the long-standing recommendation that all newborn babies should be vaccinated against hepatitis B on the day of birth.
Critics argue that this move will lead to an increase in infections among newborns, ultimately resulting in more cases of chronic liver disease, liver cancer, and premature death. Experts who opposed the change stated that there was no data supporting a delay in vaccination or evidence of harm from a birth dose.
The decision is particularly concerning as hepatitis B can be transmitted through contact with infected mothers during childbirth. Only about 50 percent of those infected are aware they carry the virus, making it difficult for new parents to protect their newborns.
Those who voted in favor of the change have no clear explanation for why two months was selected or the benefits of altering the recommendation. This move has sparked strong criticism from medical organizations and experts, including Sandra Adamson Fryhofer, a board member of the American Medical Association, who described it as "reckless" and an attempt to "disregard decades of public confidence in a proven, lifesaving vaccine."
The decision was made without any data comparing different vaccination timing or evidence of harm from a birth dose. The panel has also recommended testing a child's antibody levels after each dose of the three-dose hepatitis B series, which experts say is not supported by scientific evidence.
In essence, this move brings back memories of the infamous "Never Never Land" scenario where anything goes without any consequences, making it imperative for parents to take responsibility and make informed decisions about their children's health.
Critics argue that this move will lead to an increase in infections among newborns, ultimately resulting in more cases of chronic liver disease, liver cancer, and premature death. Experts who opposed the change stated that there was no data supporting a delay in vaccination or evidence of harm from a birth dose.
The decision is particularly concerning as hepatitis B can be transmitted through contact with infected mothers during childbirth. Only about 50 percent of those infected are aware they carry the virus, making it difficult for new parents to protect their newborns.
Those who voted in favor of the change have no clear explanation for why two months was selected or the benefits of altering the recommendation. This move has sparked strong criticism from medical organizations and experts, including Sandra Adamson Fryhofer, a board member of the American Medical Association, who described it as "reckless" and an attempt to "disregard decades of public confidence in a proven, lifesaving vaccine."
The decision was made without any data comparing different vaccination timing or evidence of harm from a birth dose. The panel has also recommended testing a child's antibody levels after each dose of the three-dose hepatitis B series, which experts say is not supported by scientific evidence.
In essence, this move brings back memories of the infamous "Never Never Land" scenario where anything goes without any consequences, making it imperative for parents to take responsibility and make informed decisions about their children's health.